| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 24, 2026 | Hamlet Biopharma Is Profiled On ‘’The Bio Report’’, One Of The Leading Biotech Podcasts In The World | Hamlet Biopharma Is Profiled On ‘’The Bio Report’’, One Of The Leading Biotech Podcasts In The World
Thu, Sep 24, 2026 13:05 CET Report this content
The Bio Report is a weekly podcast hosted by award-winning journalist, Daniel Levine. Produ... |
| Sep 21, 2026 | Hamlet BioPharma’s monthly digital investors’ meeting on September 23rd | Hamlet BioPharma’s monthly digital investors’ meeting on September 23rd
Mon, Sep 21, 2026 10:18 CET Report this content
Hamlet BioPharma invites you to our monthly investors’ meeting to be held on September 23rd 2026, at 12:00.
Please click... |
| Sep 21, 2026 | BAMLET treatment strengthens metabolic health – nutrition as a first step toward commercialization | BAMLET treatment strengthens metabolic health – nutrition as a first step toward commercialization
Mon, Sep 21, 2026 16:47 CET Report this content
New research findings defining BAMLET ‘s beneficial effects on metabolism have been published... |
| Sep 17, 2026 | Successful patient enrolment in HAMLET BioPharma’s Phase III bladder cancer trial | Successful patient enrolment in HAMLET BioPharma’s Phase III bladder cancer trial
Thu, Sep 17, 2026 08:59 CET Report this content
HAMLET BioPharma is proud to announce that the clinical phase of the Phase III trial has started. Patients wit... |
| Aug 28, 2026 | Year-end Report (Q4) July 2025 – June 2026 | Year-end Report (Q4) July 2025 – June 2026
Fri, Aug 28, 2026 09:00 CET Report this content
Strong progress in Cancer Therapy and Novel treatments of bacterial infections
“We have reached major goals in the fields of Cancer Therapy and Novel... |
| Jul 28, 2026 | Grant and impending grant of new patents in the US and Japan | Grant and impending grant of new patents in the US and Japan
Tue, Jul 28, 2026 13:00 CET Report this content
Hamlet Biopharma, a company innovating the treatment of cancer and infections, today announced the grant and impending grant of new... |
| Jul 24, 2026 | International traction for Hamlet BioPharma | International traction for Hamlet BioPharma
Fri, Jul 24, 2026 09:00 CET Report this content
Time Business News and USA Wire both highlight Hamlet Biopharma's EMA approval for the phase III study of neoaduvant therapy for early bladder cance... |
| Jun 29, 2026 | Briefglance Highlights Hamlet BioPharma's Collaboration with the University of Iowa and the Potential for Advanced Bladder Cancer Therapy | Briefglance Highlights Hamlet BioPharma's Collaboration with the University of Iowa and the Potential for Advanced Bladder Cancer Therapy
Mon, Jun 29, 2026 10:35 CET Report this content
The digital analytics platform Briefglance has highlig... |
| Jun 29, 2026 | Hamlet BioPharma Receives European Regulatory Approval for Phase III Study of Alpha1H in Bladder Cancer | Hamlet BioPharma Receives European Regulatory Approval for Phase III Study of Alpha1H in Bladder Cancer
Mon, Jun 29, 2026 14:07 CET Report this content
Hamlet BioPharma, a pharmaceutical company specializing in the development of novel trea... |
| Jun 25, 2026 | Hamlet BioPharma secures drug manufacturing at Phase III quality and release of Alpha1H for distribution to clinical trial sites | Hamlet BioPharma secures drug manufacturing at Phase III quality and release of Alpha1H for distribution to clinical trial sites
Thu, Jun 25, 2026 16:00 CET Report this content
Hamlet BioPharma today announces the successful release of the ... |
| Jun 23, 2026 | Hamlet BioPharma’s monthly digital investors’ meeting on June 30th | Hamlet BioPharma’s monthly digital investors’ meeting on June 30th
Tue, Jun 23, 2026 12:00 CET Report this content
Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 30th of June 2026, at 12:00.
Please click on... |
| Jun 22, 2026 | Clinical trial expansion in the US, in collaboration with the University of Iowa, to treat high-risk, resistant, non-muscle-invasive bladder cancer (NMIBC) | Clinical trial expansion in the US, in collaboration with the University of Iowa, to treat high-risk, resistant, non-muscle-invasive bladder cancer (NMIBC)
Mon, Jun 22, 2026 17:30 CET Report this content
Hamlet BioPharma AB (publ) today ann... |
| Jun 17, 2026 | Pre-initiation visit in Prague, for the Phase III trial of Alpha1H in bladder cancer | Pre-initiation visit in Prague, for the Phase III trial of Alpha1H in bladder cancer
Wed, Jun 17, 2026 11:45 CET Report this content
Hamlet BioPharma AB (publ) today conducted a pre-initiation visit at the Department of Urology at Charles U... |
| Jun 10, 2026 | Continued success for the new anti-infective therapies developed by Hamlet BioPharma | Continued success for the new anti-infective therapies developed by Hamlet BioPharma
Wed, Jun 10, 2026 14:30 CET Report this content
The Journal of Infectious Diseases publishes the paper “Targeting the disease response with NlpD and LytM f... |
| May 22, 2026 | Q3 INTERIMREPORTJANUARY–MARCH 2026 | Q3 INTERIMREPORTJANUARY–MARCH 2026
Fri, May 22, 2026 09:00 CET Report this content
The third quarter of 2025-2026 has been extremely productive for Hamlet BioPharma, with high-profile Phase II trial publications, establishment of clinical P... |
| May 21, 2026 | Monthly investor meeting on the 22nd of May when Hamlet BioPharma is releasing it’s Q3 report | Monthly investor meeting on the 22nd of May when Hamlet BioPharma is releasing it’s Q3 report
Thu, May 21, 2026 11:15 CET Report this content
Hamlet BioPharma invites you to the investors’ meeting to be held on the 22nd of May 2026, at 12:0... |
| May 18, 2026 | Hamlet Biopharma Secures New Patents and Allowances, Going from Strength to Strength in Innovation and Technology | Hamlet Biopharma Secures New Patents and Allowances, Going from Strength to Strength in Innovation and Technology
Mon, May 18, 2026 15:15 CET Report this content
Hamlet Biopharma, a company innovating the treatment of cancer and infections,... |
| Apr 23, 2026 | Monthly investor meeting on the 29th of April | Monthly investor meeting on the 29th of April
Thu, Apr 23, 2026 15:15 CET Report this content
Hamlet BioPharma invites you to the monthly digital investors’ meeting to be held on the 29th of April 2026, at 12:00.
Please click on the link be... |
| Mar 30, 2026 | Hamlet BioPharma presented at the Financial Stockholm event on March 26, 2026 | Hamlet BioPharma presented at the Financial Stockholm event on March 26, 2026
Mon, Mar 30, 2026 10:00 CET Report this content
Hamlet BioPharma AB, an innovative pharmaceutical company developing new therapies for cancer and infections, anno... |
| Mar 17, 2026 | Hamlet BioPharmas digital monthly investor meeting on the 18th of March | Hamlet BioPharmas digital monthly investor meeting on the 18th of March
Tue, Mar 17, 2026 10:00 CET Report this content
Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of March 2026, at 12:00.
Please cl... |
| Mar 6, 2026 | Hamlet BioPharma signed a Letter of Intent to outline terms of a potential collaboration and a commercial agreement concerning Alpha 1H. | Hamlet BioPharma signed a Letter of Intent to outline terms of a potential collaboration and a commercial agreement concerning Alpha 1H.
Fri, Mar 06, 2026 18:31 CET Report this content
Hamlet BioPharma AB (Hamlet), a clinical‑stage biopharm... |
| Feb 13, 2026 | Q2 INTERIM REPORT OCT – DEC 2025 | Q2 INTERIM REPORT OCT – DEC 2025
Fri, Feb 13, 2026 09:00 CET Report this content OPENING REMARKS
Hamlet BioPharma is identified as a mature pharmaceutical company, having reached major milestones, based on achievements of individual project... |
| Feb 11, 2026 | Monthly investor meeting on the 13th of February when Hamlet BioPharma is releasing it’s Q2 report | Monthly investor meeting on the 13th of February when Hamlet BioPharma is releasing it’s Q2 report
Wed, Feb 11, 2026 10:30 CET Report this content
Hamlet BioPharma invites you to our February investors’ meeting to be held on the 13th of Feb... |
| Feb 3, 2026 | Collaboration agreement between Hamlet BioPharma and Immunoforge in South Korea | Collaboration agreement between Hamlet BioPharma and Immunoforge in South Korea
Tue, Feb 03, 2026 10:15 CET Report this content
Hamlet BioPharma has signed an agreement with the Korean biotech company ImmunoForge, to develop novel administr... |
| Jan 27, 2026 | 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 | 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿
Tue, Jan 27, 2026 12:00 CET Report this content
We warmly welcome you to the Symposium on “𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿.” The invited speaker ...... |
| Jan 16, 2026 | Invitation to digital meeting focusing on novel strategies for treating bacterial infections without antibiotics | Invitation to digital meeting focusing on novel strategies for treating bacterial infections without antibiotics
Fri, Jan 16, 2026 14:00 CET Report this content
Welcome to Hamlet BioPharma’s monthly digital meeting on January 21 at 12:00, h... |
| Nov 14, 2025 | Q1 INTERIM REPORT JULY – SEPT 2025 | Q1 INTERIM REPORT JULY – SEPT 2025
Fri, Nov 14, 2025 09:00 CET Report this content
OPENING REMARKS
The 2024-2025 financial year was extremely productive for Hamlet BioPharma and this trend continued into the first quarter of the financial y... |
| Nov 10, 2025 | Hamlet BioPharma Receives FDA Pivotal-Study Feedback for Novel Neoadjuvant Therapy in Non–Muscle Invasive Bladder Cancer | Hamlet BioPharma Receives FDA Pivotal-Study Feedback for Novel Neoadjuvant Therapy in Non–Muscle Invasive Bladder Cancer
Mon, Nov 10, 2025 09:00 CET Report this content
HAMLET BioPharma, a clinical‑stage biopharmaceutical company advancing ... |
| Oct 24, 2025 | A new approach to treating bacterial infections without antibiotics - targeting the disease response rather than the bacteria | A new approach to treating bacterial infections without antibiotics - targeting the disease response rather than the bacteria
Fri, Oct 24, 2025 16:10 CET Report this content
New molecular concepts for the treatment of bacterial infections w... |
| Oct 24, 2025 | Clinical studies paving the way for non-antibiotic treatments of bacterial infections; details from the large-scale international study in infants | Clinical studies paving the way for non-antibiotic treatments of bacterial infections; details from the large-scale international study in infants
Fri, Oct 24, 2025 16:10 CET Report this content
Hamlet BioPharma, the pharmaceutical company,... |
| Sep 23, 2025 | Monthly investor meeting on the 25th of September | Monthly investor meeting on the 25th of September
Tue, Sep 23, 2025 09:00 CET Report this content
Hamlet BioPharma invites you to our September investors’ meeting to be held on the 25th of September 2025, at 12:00.
Please click on the link ... |
| Sep 22, 2025 | Hamlet BioPharma prepares for next steps and secures drug manufacturing of Alpha1H at Phase III quality | Hamlet BioPharma prepares for next steps and secures drug manufacturing of Alpha1H at Phase III quality
Mon, Sep 22, 2025 13:53 CET Report this content
Hamlet BioPharma, ticker Hamlet, the pharmaceutical company specializing in the developm... |
| Sep 9, 2025 | Hamlet BioPharma secures new patents to develop scientific discoveries into drugs for the treatment of cancer and infections | Hamlet BioPharma secures new patents to develop scientific discoveries into drugs for the treatment of cancer and infections
Tue, Sep 09, 2025 12:35 CET Report this content
Hamlet BioPharma, a global leader in the treatment of cancer and in... |
| Sep 4, 2025 | Doctoral thesis to be defended today: Title ‘’Tumor response mechanisms and treatment effects of alpha1-oleate’’ | Doctoral thesis to be defended today: Title ‘’Tumor response mechanisms and treatment effects of alpha1-oleate’’
Thu, Sep 04, 2025 10:38 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development o... |
| Aug 28, 2025 | Year-end Report (Q4) July 2024 – June 2025 | Year-end Report (Q4) July 2024 – June 2025
Thu, Aug 28, 2025 09:00 CET Report this content
OPENING REMARKS
The fiscal year of 2024-2025 has been extremely productive in Hamlet BioPharma, including the fourth quarter (Q4). The company has su... |
| Aug 21, 2025 | Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer | Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer
Thu, Aug 21, 2025 11:15 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of d... |
| Jul 18, 2025 | Hamlet BioPharma proposes a directed new share issue to finance continued development and commercialization based on three positive Phase II studies | Hamlet BioPharma proposes a directed new share issue to finance continued development and commercialization based on three positive Phase II studies
Fri, Jul 18, 2025 14:58 CET Report this content
Lund, 18 July 2025, Hamlet BioPharma, an in... |
| Jun 25, 2025 | Hamlet BioPharma Holds Successful In Person Meeting with US FDA | Hamlet BioPharma Holds Successful In Person Meeting with US FDA
Wed, Jun 25, 2025 15:50 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announce... |
| Jun 17, 2025 | Hamlet BioPharma invites to investor meeting on the 18th of June | Hamlet BioPharma invites to investor meeting on the 18th of June
Tue, Jun 17, 2025 10:00 CET Report this content
As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the18th of June 2025, at 1... |
| May 22, 2025 | Q3 INTERIM REPORT JANUARY – MARCH 2025 | Q3 INTERIM REPORT JANUARY – MARCH 2025
Thu, May 22, 2025 09:00 CET Report this content
OPENING REMARKS
Hamlet BioPharma’s drug candidate Alpha1H has shown effective tumor-killing capabilities against bladder cancer cells and demonstrated st... |
| May 19, 2025 | Scientific Breakthrough in Alpha1H’s Mechanism of Action | Scientific Breakthrough in Alpha1H’s Mechanism of Action
Mon, May 19, 2025 13:21 CET Report this content
As previously reported, Hamlet BioPharma has achieved a groundbreaking scientific discovery related to Alpha1H, the company’s lead drug... |
| Apr 22, 2025 | Hamlet BioPharma invites to investor meeting on the 23rd of April | Hamlet BioPharma invites to investor meeting on the 23rd of April
Tue, Apr 22, 2025 14:38 CET Report this content
As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 23rd of April 2025, a... |
| Apr 7, 2025 | Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA | Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA
Mon, Apr 07, 2025 16:32 CET Report this content
Hamlet BioPharma, the pharmace... |
| Feb 20, 2025 | The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value for both companies | The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value for both companies
Thu, Feb 20, 2025 13:11 CET Report this content
Haml... |
| Feb 13, 2025 | Q2 Interim Report October 2024 – December 2024 | Q2 Interim Report October 2024 – December 2024
Thu, Feb 13, 2025 09:00 CET Report this content
OPENING REMARKS
Hamlet BioPharma has conducted three successful Phase II studies, showing efficacy of our drug candidates in three different clin... |
| Jan 10, 2025 | Invitation to monthly digital events and presentations of quarterly report | Invitation to monthly digital events and presentations of quarterly report
Fri, Jan 10, 2025 15:54 CET Report this content
Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These eve... |
| Nov 28, 2024 | Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024 | Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024
Thu, Nov 28, 2024 13:25 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and... |
| Nov 19, 2024 | Hamlet BioPharma Participates in the BioStock Life Science Summit 2024 | Hamlet BioPharma Participates in the BioStock Life Science Summit 2024
Tue, Nov 19, 2024 16:49 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announc... |
| Nov 4, 2024 | Hamlet BioPharma will present at the BioStock Life Science Summit, November 20 | Hamlet BioPharma will present at the BioStock Life Science Summit, November 20
Mon, Nov 04, 2024 11:00 CET Report this content
The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. Chair Catharin... |
| Nov 4, 2024 | Two in-depth features about Hamlet BioPharma in the prestigious CEO world magazines and pulse 2.0 business news website | Two in-depth features about Hamlet BioPharma in the prestigious CEO world magazines and pulse 2.0 business news website
Mon, Nov 04, 2024 10:33 CET Report this content
Hamlet BioPharma, ticker HAMLET B, the innovative pharmaceutical company... |
| Sep 26, 2024 | Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics | Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics
Thu, Sep 26, 2024 12:08 CET Report this content
Hamlet BioPharma -... |
| Sep 13, 2024 | New Frontiers in Bladder Cancer Treatment and Alzheimer’s Research: A Dual Perspective | In the realm of medical science, breakthroughs often come with the force of a tidal wave. Two recent studies highlight this dynamic, one focusing on bladder cancer and the other on Alzheimer’s disease. Each represents a significant leap for... |
| Sep 13, 2024 | The Healing Power of Human Milk: A New Frontier in Cancer Treatment | In a world where science often feels like a maze, a beacon of hope shines through the research on human breast milk. The recent feature in *The Economist* highlights groundbreaking work from Lund University, focusing on a compound known as ... |
| Sep 12, 2024 | The Economist features groundbreaking research on human breast milk and the story of HAMLET | The Economist features groundbreaking research on human breast milk and the story of HAMLET
Thu, Sep 12, 2024 10:55 CET Report this content
Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a... |
| Sep 11, 2024 | Alpha1H treatment shows strong effects in patients with bladder cancer in final analysis published in Cancer Medicine | Alpha1H treatment shows strong effects in patients with bladder cancer in final analysis published in Cancer Medicine
Wed, Sep 11, 2024 13:26 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the developm... |
| Aug 28, 2024 | Year-end Report (Q4) July 2023 – June 2024 | Year-end Report (Q4) July 2023 – June 2024
Wed, Aug 28, 2024 09:49 CET Report this content
OPENING REMARKS
The fiscal year 2023-2024 has been very productive, eventful and successful for Hamlet Biopharma, addressing the need for new treatme... |
| Aug 22, 2024 | Invitation to monthly digital events and presentations of quarterly reports | Invitation to monthly digital events and presentations of quarterly reports
Thu, Aug 22, 2024 10:26 CET Report this content
Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provi... |
| Jun 20, 2024 | Hamlet BioPharma, the innovative pharmaceutical company, with a strong portfolio of projects, for the treatment of cancer and infections, is featured in this weekend issue of The Guardian | Hamlet BioPharma, the innovative pharmaceutical company, with a strong portfolio of projects, for the treatment of cancer and infections, is featured in this weekend issue of The Guardian
Thu, Jun 20, 2024 11:02 CET Report this content
Haml... |
| May 27, 2024 | Hamlet BioPharma Participates in The Global Forum 2024 | Hamlet BioPharma Participates in The Global Forum 2024
Mon, May 27, 2024 13:30 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participat... |
| May 24, 2024 | Q3 Interim Report January - March 2024 | Q3 Interim Report January - March 2024
Fri, May 24, 2024 09:00 CET Report this content
About Hamlet BioPharma
Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of cance... |
| Apr 11, 2024 | Alpha1H to be the first asset for the commercial collaboration | Alpha1H to be the first asset for the commercial collaboration
Thu, Apr 11, 2024 16:12 CET Report this content
Hamlet BioPharma - the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, ann... |
| Mar 27, 2024 | Hamlet BioPharma arranges a new series of digital events | Hamlet BioPharma arranges a new series of digital events
Wed, Mar 27, 2024 10:17 CET Report this content
Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline,... |
| Mar 26, 2024 | Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024 | Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024
Tue, Mar 26, 2024 10:28 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and... |
| Mar 6, 2024 | Hamlet BioPharma Participates in Swiss Nordic Bio 2024 | Hamlet BioPharma Participates in Swiss Nordic Bio 2024
Wed, Mar 06, 2024 09:39 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce it... |
| Feb 22, 2024 | Q2 Interim Report October - December 2023 | Q2 Interim Report October - December 2023
Thu, Feb 22, 2024 09:00 CET Report this content
About Hamlet BioPharma
Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of ca... |
| Feb 14, 2024 | Hamlet BioPharma Enters Commercial Collaborations with Top International Advisory Firms to Enhance Partnering and Strategic Alliances | Hamlet BioPharma Enters Commercial Collaborations with Top International Advisory Firms to Enhance Partnering and Strategic Alliances
Wed, Feb 14, 2024 11:21 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing... |
| Jan 25, 2024 | New analyses of clinical data from Alpha1H treated patients with bladder cancer detect a strong immune response with known anti-tumor effects | New analyses of clinical data from Alpha1H treated patients with bladder cancer detect a strong immune response with known anti-tumor effects
Thu, Jan 25, 2024 11:56 CET Report this content
Hamlet BioPharma’s drug candidate Alpha1H has been... |
| Jan 10, 2024 | Hamlet BioPharma featured at MSQ’s CEO Webinar series released during the JP Morgan Health Care Conference 2024 | Hamlet BioPharma featured at MSQ’s CEO Webinar series released during the JP Morgan Health Care Conference 2024
Wed, Jan 10, 2024 14:53 CET Report this content
Hamlet BioPharma, the innovative pharmaceutical company currently advancing seve... |
| Jan 9, 2024 | Immunotherapy - a new approach to treating bacterial infections, including antibiotic resistant strains | Immunotherapy - a new approach to treating bacterial infections, including antibiotic resistant strains
Tue, Jan 09, 2024 17:04 CET Report this content
Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phas... |
| Dec 20, 2023 | Antimicrobial peptide therapy for tuberculosis infections | Antimicrobial peptide therapy for tuberculosis infections
Wed, Dec 20, 2023 13:27 CET Report this content
Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and ... |
| Dec 13, 2023 | Hamlet BioPharma Announces the Nomination of Elisabeth Parker to its Board of Directors | Hamlet BioPharma Announces the Nomination of Elisabeth Parker to its Board of Directors
Wed, Dec 13, 2023 16:45 CET Report this content
Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targ... |
| Dec 11, 2023 | Hamlet BioPharma is inviting you to join a digital presentation at Invest Live, Tuesday December 12[th] at 12.00 CET | Hamlet BioPharma is inviting you to join a digital presentation at Invest Live, Tuesday December 12[th] at 12.00 CET
Mon, Dec 11, 2023 15:24 CET Report this content
Hamlet BioPharma, the innovative pharmaceutical company currently advancing... |
| Dec 6, 2023 | Hamlet BioPharma’s continued development of brain tumor therapy | Hamlet BioPharma’s continued development of brain tumor therapy
Wed, Dec 06, 2023 16:57 CET Report this content
Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infec... |
| Nov 29, 2023 | Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer | Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer
Wed, Nov 29, 2023 09:29 CET Report this content
Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the ... |
| Nov 2, 2023 | Newsletter from Hamlet Biopharma | Newsletter from Hamlet Biopharma
Thu, Nov 02, 2023 12:09 CET Report this content
Hamlet Biopharma
An innovative pharmaceutical company with a wide and robust portfolio of projects for the treatment of cancer and infections.
Cancer
A central... |
| Oct 30, 2023 | Hamlet BioPharma presented at the FS Market event on October 25th | Hamlet BioPharma presented at the FS Market event on October 25th
Mon, Oct 30, 2023 14:44 CET Report this content
The company was presented by Catharina Svanborg and Jan Zetterberg.
To view the presentation, please use the link bekow:
https... |
| Jul 1, 2023 | FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer | FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer
Sat, Jul 01, 2023 15:59 CET Report this content
Hamlet Pharma is proud to announce today that the U.S. Food and Drug Administration (FDA) h... |
| Jul 1, 2023 | FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer | FDA Clearance of IND Application for Alpha1H for the treatment of non-muscle invasive bladder cancer
Sat, Jul 01, 2023 15:59 CET Report this content
Hamlet Pharma is proud to announce today that the U.S. Food and Drug Administration (FDA) h... |
| Jun 30, 2023 | Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma | Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma
Fri, Jun 30, 2023 09:25 CET Report this content
Hamlet Pharma, soon to be Hamlet BioPharma, the innovative pharmaceutical company with several projects in Phase II trials in infec... |
| Jun 30, 2023 | Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma | Petter Segelman Lindqvist appointed new CEO of Hamlet Pharma
Fri, Jun 30, 2023 09:25 CET Report this content
Hamlet Pharma, soon to be Hamlet BioPharma, the innovative pharmaceutical company with several projects in Phase II trials in infec... |
| Jun 12, 2023 | Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group | Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group
Mon, Jun 12, 2023 13:14 CET Report this content
Lund, June 12, Hamlet Pharma, ticker HAMLET, soon to be Hamlet BioPharma, the innovative pharma... |
| Jun 12, 2023 | Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group | Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group
Mon, Jun 12, 2023 13:14 CET Report this content
Lund, June 12, Hamlet Pharma, ticker HAMLET, soon to be Hamlet BioPharma, the innovative pharma... |
| May 31, 2023 | Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials | Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials
Wed, May 31, 2023 10:20 CET Report this content
Lund, May 31, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong ... |
| May 31, 2023 | Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials | Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials
Wed, May 31, 2023 10:20 CET Report this content
Lund, May 31, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong ... |
| May 22, 2023 | Introducing Hamlet BioPharma to investors | Introducing Hamlet BioPharma to investors
Mon, May 22, 2023 10:10 CET Report this content
Hamlet BioPharma the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections today launches t... |
| May 22, 2023 | Introducing Hamlet BioPharma to investors | Introducing Hamlet BioPharma to investors
Mon, May 22, 2023 10:10 CET Report this content
Hamlet BioPharma the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections today launches t... |
